Clinical Trial Update: A Self-Controlled Study on the Treatment of Restless Legs Syndrome in Uremia With Dipyridamole [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial update announces ongoing Phase 2/Phase 3 studies evaluating dipyridamole for restless legs syndrome due to uraemia, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Restless Legs Syndrome

Drugs mentioned

• Dipyridamole (Dipyridamole)

Snippet

Sponsor: Yunfeng Xia | Conditions: Restless Leg Syndrome Due to Uraemia | Phase 2, Phase 3 | Status: RECRUITING